Key statistics
On Friday, HLS Therapeutics Inc (HLS:TOR) closed at 4.86, -7.07% below its 52-week high of 5.23, set on May 28, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.88 |
---|---|
High | 4.88 |
Low | 4.81 |
Bid | 4.85 |
Offer | 5.00 |
Previous close | 4.83 |
Average volume | 13.53k |
---|---|
Shares outstanding | 31.56m |
Free float | 31.51m |
P/E (TTM) | -- |
Market cap | 153.37m CAD |
EPS (TTM) | -0.774 CAD |
Data delayed at least 15 minutes, as of Jul 11 2025 20:59 BST.
More ▼
- HLS Therapeutics Announces Reimbursement for Vascepa® under Nova Scotia's Provincial Drug Plan
- HLS Therapeutics Reports Annual Meeting Results
- HLS Therapeutics Announces Q1 2025 Financial Results
- HLS Therapeutics partners with Esperion Therapeutics to commercialize NEXLETOL® and NEXLIZET® in Canada
- HLS Therapeutics to Present at the 2025 Bloom Burton & Co. Healthcare Investor Conference
- HLS Therapeutics to Host Q1 2025 Financial Results Conference Call
More ▼